ZUMA-1 study

The ZUMA-1 study is a clinical trial that investigated the effectiveness of a treatment called CAR T-cell therapy for patients with aggressive forms of lymphoma, a type of blood cancer. In this approach, doctors modify a patient's own immune cells to better target and attack cancer cells. The ZUMA-1 study specifically looked at how well this therapy worked in patients who had not responded to previous treatments. Results showed that a significant number of patients experienced a complete or partial response, indicating that CAR T-cell therapy can be a promising option for difficult-to-treat lymphoma cases.